Viscosupplementation Market Size, Share, Analysis and Forecasts, 2016 To 2020

Global Viscosupplementation Market Size, Share, Strategies, Global
Insights, Analysis and Forecasts, 2016 To 2020
Technavio Announces the Publication of its Research Report Global Viscosupplementation Market 2016-
2020
Technavio recognizes the following companies as the key players in the global Viscosupplementation
market: Sanofi, Anika Therapeutics, Seikagaku, Fidia Farmaceutici, and Ferring Pharmaceuticals.
Other Prominent Vendors in the market are: Allergan, Contipro Biotech, DePuy Synthes, F. Hoffmann-La
Roche, Galderma, HTL Biotechnology, Hyaltech, Expanscience Laboratoires, Lifecore Biomedical, Lipo
Chemicals, Merz Aesthetics, Mylan, Nordic Drugs, Shandong Freda Biochem, Shanghai Jingfeng
Pharmaceutical, Smith & Nephew, TEIJIN PHARMA, and TRB Chemedica International.
Browse full report with TOC @ https://marketreportscenter.com/reports/470044/globalviscosupplementation-market-2016-2020
Commenting on the report, an analyst from Technavio’ s team said: “The shift in consumer preference
from cheaper five-injection cycle products to premium priced single-injection cycle products is a major
positive trend being witnessed in the market in recent years. Despite its exorbitant cost, consumers are
increasingly going for single-injection cycle viscosupplements because of shorter treatment time.”
According to the report, fast-growing geriatric population is the major driver driving growth in the
market. A rising concern worldwide is the fast-growing elderly population, especially in the major
countries such as Japan, South Korea, China, Germany, and the US. The geriatric people in these
countries are affected by a wide range of chronic diseases such as cancer, liver, osteoarthritis, and
kidney diseases.
Further, the report states that the increase in the number of substitutes for viscosupplementation is the
major challenge being faced by the manufacturers in the market. NSAIDs, knee replacement devices,
cyclooxygenase inhibitors, and joint arthroplasty devices are the substitutes for viscosupplements used
in the treatment of knee osteoarthritis.
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market and
vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/470044

About Viscosupplementation
Viscosupplementation is a minimally invasive treatment for knee osteoarthritis. It involves the injection
of hyaluronic acid into a knee joint to assist the viscous properties of synovial fluid. The procedure
increases the joint’ s functioning and reduces pain. Intra-articular viscosupplementation with hyaluronic
acid is gaining acceptance as it is a non-invasive procedure compared to knee replacement. It is
categorized into three product segments single-injection cycle, three-injection cycle, and five-injection
cycle.
Technavio’ s analysts forecast the global Viscosupplementation market to grow at a CAGR of 6.23%
during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global Viscosupplementation
market for 2016-2020. To calculate the market size, the report considers the revenue generated from
the sale of products in different regions.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Viscosupplementation Market 2016-2020, has been prepared based on an indepth
market analysis with inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors
operating in this market.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/470044
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
info@marketreportscenter.com